About CardioMEMS
CardioMEMS is a company based in Atlanta (United States) founded in 2001 was acquired by St. Jude Medical in May 2014.. CardioMEMS has raised $166.98 million across 5 funding rounds from investors including Medtronic, St. Jude Medical and CIFC Asset Management. CardioMEMS offers products and services including CardioMEMS HF System. CardioMEMS operates in a competitive market with competitors including iRhythm Tech, Endotronix, Cardiotrack, ZOLL AEDs and Avertix, among others.
- Headquarter Atlanta, United States
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cardiomems, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$166.98 M (USD)
in 5 rounds
-
Latest Funding Round
$60 M (USD), Series G
Sep 16, 2010
-
Investors
Medtronic
& 14 more
-
Employee Count
Employee Count
-
Acquired by
St. Jude Medical
(May 28, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CardioMEMS
CardioMEMS offers a comprehensive portfolio of products and services, including CardioMEMS HF System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Monitors pulmonary artery pressures to prevent heart failure worsening.
Funding Insights of CardioMEMS
CardioMEMS has successfully raised a total of $166.98M across 5 strategic funding rounds. The most recent funding activity was a Series G round of $60 million completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series G — $60.0M
-
First Round
First Round
(20 Nov 2003)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2010 | Amount | Series G - CardioMEMS | Valuation |
investors |
|
| May, 2010 | Amount | Series F - CardioMEMS | Valuation |
investors |
|
| Aug, 2009 | Amount | Series E - CardioMEMS | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CardioMEMS
CardioMEMS has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, St. Jude Medical and CIFC Asset Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments in real estate are managed by Arcapita.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CardioMEMS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CardioMEMS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cardiomems Comparisons
Competitors of CardioMEMS
CardioMEMS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iRhythm Tech, Endotronix, Cardiotrack, ZOLL AEDs and Avertix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| domain | founded_year | HQ Location |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| domain | founded_year | HQ Location |
AI-based EGC data capture and analysis platform
|
|
| domain | founded_year | HQ Location |
Medical devices and software for emergency care are developed.
|
|
| domain | founded_year | HQ Location |
An implantable warning system for heart attack detection is provided.
|
|
| domain | founded_year | HQ Location |
Develops and markets the Carnation Ambulatory Monitor
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CardioMEMS
When was CardioMEMS founded?
CardioMEMS was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Where is CardioMEMS located?
CardioMEMS is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Is CardioMEMS a funded company?
CardioMEMS is a funded company, having raised a total of $166.98M across 5 funding rounds to date. The company's 1st funding round was a Series E of $22.1M, raised on Nov 20, 2003.
What does CardioMEMS do?
CardioMEMS develops and commercializes a wireless sensing and communication technology for the heart. The companys technology improves the management of chronic cardiovascular diseases, such as heart failure(, hypertension, and aneurysms. The companys miniature wireless sensors are implanted using minimally invasive techniques, which transmit cardiac output, blood pressure, and heart rate data. Its products include the CardioMEMS HF System and EndoSure Wireless AAA Pressure Measurement System that is inserted during the minimally invasive endovascular repair of abdominal aortic aneurysms or AAA through a catheter into a patients aneurysm sac, which measures and communicates pressure information to an external electronics module from inside the sac.
Who are the top competitors of CardioMEMS?
CardioMEMS's top competitors include iRhythm Tech, Endotronix and ZOLL AEDs.
What products or services does CardioMEMS offer?
CardioMEMS offers CardioMEMS HF System.
Who are CardioMEMS's investors?
CardioMEMS has 15 investors. Key investors include Medtronic, St. Jude Medical, CIFC Asset Management, Guidant, and Arcapita.